Back to Blogs
  • Publish Date: Posted 4 months ago
  • Author: Nick Mahoney

Ep 7 | Building an AI platform to tackle complex diseases

In the final episode of series 2, Nick is joined by Dr. Muhunthan Thillai, the co-founder and CEO of Qureight and they discuss the innovative way they are using AI to allow for effective drug development in complex diseases. This is also a fantastic episode for understanding how founders from a medical background have built an AI company. 

Dr. Muhunthan Thillai is the co-founder and CEO of Qureight, a medical technology company in Cambridge which aims to pioneer data curation in complex diseases. By structuring image and biomarker data from biopharma and healthcare institutions, Qureight uses their AI-assisted platform to look for new trial endpoints in complex diseases including Idiopathic Pulmonary Fibrosis, Lung Cancer and Pulmonary Hypertension.

To speak to Nick, please drop an email to n.mahoney@sciproglobal.com

Listen:
Apple > https://apple.co/3qvIgN2
Spotify > https://spoti.fi/3qvwQsW
Anchor > https://anchor.fm/scipro